Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00488449 · ClinicalTrials.gov registry record · Phase 1
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00488449 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 56 participants.
The verdict
NCT00488449, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects.
Interventions
- DRUG GSK256073A tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00488449
The ClinicalTrials.gov registry entry for NCT00488449 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK256073A tablets is the first listed.
NCT00488449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00488449 about?
NCT00488449 is a clinical study titled "Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers". The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects.
What is the current status of trial NCT00488449?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2007-06. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00488449?
The interventions under investigation include: GSK256073A tablets (DRUG).
Who is sponsoring clinical trial NCT00488449?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.